Diabetic Retinopathy: BI 764524 Treatment Study

We are testing whether the new treatment BI 764524 can improve eye health in people with diabetic retinopathy. The study will compare its effects to a placebo to see if it helps prevent serious vision problems.

6-12 months 11-15 visits Efficacy phase (II)Investigational Medicines InjectionEndocrinologyOphthalmology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Biotin

Biotin is a B vitamin that helps the body convert food into energy and supports healthy hair, skin, and nails.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Bi 764524

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Universitaetsklinikum Bonn AöR

DEU5: Augenklinik

Bonn, Germany

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

DEU4: Augenklinik und Poliklinik

Mainz, Germany

Diakonie Klinikum Dietrich Bonhoeffer GmbH

DEU1: Augenheilkunde

Neubrandenburg, Germany

Sponsor: Boehringer Ingelheim International GmbH

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.